可注射水凝中含有三重准miRNA的核心外纳米颗粒使得糖尿病伤口的协调修复成为可能
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Prosthodontics School of Stomatology, The Fourth Military Medical University, Xi An, 710032, China.
Journal of nanobiotechnology
|December 9, 2025
概括
一种新的纳米粒子系统 (miR-RPC) 有效地向巨细胞,内皮细胞和纤维细胞,通过协调免疫反应,血管形成和原蛋白生产来加速糖尿病伤口愈合.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 纳米技术 纳米技术
背景情况:
- 糖尿病伤口愈合受到异常巨细胞极化,内皮功能减弱和纤维细胞活性下降的影响.
- 现有的疗法通常针对单细胞类型,未能解决糖尿病伤口中复杂的细胞失调问题.
- 持续的高血糖会破坏有效的伤口修复所必需的关键细胞过程.
研究的目的:
- 开发和评估一种新型的三重准核心外纳米粒子 (miR-RPC),用于糖尿病伤口愈合中的巨细胞,内皮细胞和纤维细胞的协调调节.
- 为了利用共享的整合素αvβ3受体进行针对性的miR-146a-5p的输送.
- 评估miR-RPC在水凝系统中结合的治疗疗效,以加速糖尿病伤口修复.
主要方法:
- 核心外纳米颗粒 (miR-RPC) 的制造,其中包括RGD/酸 (PS) 修饰的脂质外和酸/miR-146a-5p核心.
- 利用静电相互作用和RGD,通过整合素αvβ3.3进行向的输送.
- 将miR-RPC纳入GelMA/OHA水凝 (GelO) 中,并评估其对细胞功能的影响,以及大鼠糖尿病伤口模型.
主要成果:
- miR-RPC成功地将巨细胞重新编程为M2表型,在高葡萄糖下增强内皮细胞血管生成能力,并促进纤维细胞增殖,迁移和原分泌.
- miR-RPC@GelO水凝显著加速了大鼠的糖尿病伤口愈合,通过减少炎症,增加血管化和增加原沉积来证明这一点.
- 该系统通过免疫调节,血管生成和原沉积表现出协同效应.
结论:
- 三重准的miR-RPC纳米粒子系统通过同时解决关键细胞缺陷,为协调糖尿病伤口修复提供了一个有希望的策略.
- miR-RPC@GelO水凝通过协同免疫调节,血管生成和原沉积有效促进糖尿病伤口愈合.
- 这项研究强调了离子脂在RNA传递中的潜力,以及miR-RPC作为再生医学的基因传递载体的多功能性.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
01:31Diabetic Foot Ulcer
33
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
33
01:27Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
01:22Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59